Adrian O Rodriguez, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2301 21st Ave S, Nashville, TN 37212 Phone: 615-327-9797 Fax: 615-613-0329 |
Stephen John Malachowski, MD Dermatology Medicare: Medicare Enrolled Practice Location: 719 Thompson Lane, Vanderbilt Dermatology, Suite 26300, Nashville, TN 37204 Phone: 615-322-6485 |
Dr. Rachel Redenius Howald, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2301 21st Ave S, Nashville, TN 37212 Phone: 615-327-9797 Fax: 615-613-0329 |
Nelson Sanchez, MD Dermatology Medicare: Medicare Enrolled Practice Location: 719 Thompson Ln Ste 26300, Nashville, TN 37204 Phone: 615-322-6485 |
News Archive
Congenica, a clinical interpretation partner for the UK 100,000 Genomes Project, has announced that its whole genome analysis platform Sapientia™ is detecting clinically relevant variants in over 35% of diagnostics reports returned to the NHS Genomic Medicine Centres (GMCs) for the Pilot and Main Phase studies.
Childhood obesity rates have nearly tripled in the previous 30 years and researchers are asking the important question of how this epidemic will impact the future health of these obese children and public health in general. A University of Colorado Cancer Center article recently published in the journal Gerontology shows that even in cases in which obese children later lose weight, the health effects of childhood obesity may be long-lasting and profound.
DaVita Inc., a leading provider of kidney care services committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), announced today that it has closed its acquisition of DSI Renal, Inc.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has shipped its first commercial order of DAVANAT® to PROCAPS S.A., a large, international pharmaceutical company based in Barranquilla, Colombia. The $200,000 shipment of DAVANAT® will be used by PROCAPS to qualify its vial filling process.
Integra LifeSciences Holdings Corp will feature the new Integra™ Flow Regulating Valve, Mini, a smaller version of the Integra NPH™ Low Flow Valve, at the 2010 Congress of Neurological Surgeons Annual Meeting in San Francisco, California, October 16-21, 2010. The Integra™ Flow Regulating Valve, Mini is Integra's newest implantable shunt valve used in the management of hydrocephalus and was designed with a lower profile than the Integra NPH™ valve to accommodate various patient populations, particularly patients with thin, fragile skin.
› Verified 6 days ago